Hint mode is switched on Switch off
For swift navigation between sections

SpyGlass Pharma

PDF download

Choose all Reset all
Download Cancel
Organization name
SpyGlass Pharma, Inc.
Country name
USA
Country of registration
USA
Industry
Medical Devices
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.

Awards

News

26/03/2026 SpyGlass Pharma: Results Of Operations And Financial Condition, Financial Statements And Exhibits
09/03/2026 SpyGlass Pharma: Other Events, Financial Statements And Exhibits
12/02/2026 SpyGlass Pharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
05/02/2026 SpyGlass Pharma: On This Form 8k, Including Exhibit 99.1 Attached Hereto, Shall Not Be Deemed “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference Into Any Other Filing Under The Securities Act Or The Exchange Act, Except As Expressly Set Forth By Specific Reference In Such A Filing, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • CIK
    0001778922
  • EIN
    83-3044245
Registration is required to get access.